Obstructive Sleep Apnea and Sarcoidosis Interactions.
Apnea
Fatigue
Hypoventilation
Overlap
Sarcoidosis
Journal
Sleep medicine clinics
ISSN: 1556-4088
Titre abrégé: Sleep Med Clin
Pays: United States
ID NLM: 101271531
Informations de publication
Date de publication:
Jun 2024
Jun 2024
Historique:
medline:
2
5
2024
pubmed:
2
5
2024
entrez:
1
5
2024
Statut:
ppublish
Résumé
Obstructive sleep apnea (OSA) is very prevalent in sarcoidosis patients. Sarcoidosis of the upper respiratory tract may affect upper airway patency and increase the risk of OSA. Weight gain due to steroid use, upper airway myopathy due to steroids and sarcoidosis itself, and interstitial lung disease with decreased upper airway patency are other reasons for the higher OSA prevalence seen in sarcoidosis. Several clinical manifestations such as fatigue, hypersomnolence, cognitive deficits, and pulmonary hypertension are common to both OSA and sarcoidosis. Therefore, early screening and treatment for OSA can improve symptoms and overall patient quality of life.
Identifiants
pubmed: 38692754
pii: S1556-407X(24)00020-1
doi: 10.1016/j.jsmc.2024.02.010
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
295-305Informations de copyright
Copyright © 2024 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure Dr C. Lal is a consultant for Jazz pharmaceuticals, Chest/GSK, and Idorsia pharmaceuticals.